# Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial

Study · id `cardio:ct-nct01858077` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01858077](<https://clinicaltrials.gov/study/NCT01858077>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01858077

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 1845 participants.

## Technical summary

Registry record NCT01858077. Randomized; single masking; primary purpose treatment. Start 2013-08 (registry gives no type); primary completion 2017-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1845 participants (enrolled count; ClinicalTrials.gov record NCT01858077, source copy `cardio:ctgov-nct01858077-2019-01-09`, retrieved 2026-10-26)
- Start date: 2013-08 (registry gives no type) (ClinicalTrials.gov record NCT01858077, source copy `cardio:ctgov-nct01858077-2019-01-09`, retrieved 2026-10-26)
- Primary completion: 2017-12 (actual) (ClinicalTrials.gov record NCT01858077, source copy `cardio:ctgov-nct01858077-2019-01-09`, retrieved 2026-10-26)
- Completion: 2020-12 (anticipated) (ClinicalTrials.gov record NCT01858077, source copy `cardio:ctgov-nct01858077-2019-01-09`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT01858077, source copy `cardio:ctgov-nct01858077-2019-01-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01858077-2019-01-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial
- Acronym: AIDA
- Condition: Coronary Artery Disease
- Condition: Myocardial Infarction
- Intervention (Device): ABSORB BVS™
- Intervention (Device): XIENCE™
- Lead sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (`cardio:org-academisch-medisch-centrum-universiteit-van-amsterdam-amc-662d32`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial (`cardio:pubmed-34483094`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b91bc02f04af0adccc169193a57197ad18539e59ed9332dfa2587e3f1ef0da18
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
